APPLICATION
ANDA207471
TYPE
ANDA
ORIGINAL APPROVAL
2022-06-24
LATEST ACTION
2024-05-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
AMOXICILLINPrescription
AMOXICILLIN 500MG · CAPSULE · ORAL
AMOXICILLINPrescription
AMOXICILLIN 250MG · CAPSULE · ORAL
Approval history
2024-05-01Labeling · Supplement 2 · standardAP
2022-06-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.